Once the MVE starts to fall out, and I don't pair these businesses together, they're totally different businesses and they're totally -- serve totally different parts of the market with totally different missions. So I'll take them one at a time. On MVE, I think once it pulls out of this lull, I think you will be able to assume the growth rates are maybe even a little bit better than single digits, maybe in the low double digits once it's out of this low. So what created the low and what created this? We do ...

CryoPort, Inc. (CYRX) came out with a quarterly loss of $0.51 per share versus the Zacks Consensus Estimate of a loss of $0.32. This compares to loss of $0.24 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -59.38%. A quarter ago, it was expected that this company would post a loss of $0.31 per share when it actually produced a loss of $0.31, delivering no surprise.Over the last four quarters, the company has surpassed consens ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Nevada 88-0313393 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 112 Westwood Place, Suite 350 Brentwood, TN 37027 (Address of principal executive offices, including zip code) FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 □ TRANSITION REPORT PURSUANT TO SECTION 1 ...

Exhibit 99.1 Cryoport Reports Fourth Quarter and Full Year 2023 Financial Results "Product revenues were lower than historical levels; however, MVE Biological Solutions' revenue began to stabilize in the latter part of the year. Moreover, MVE continues to be a strong business unit, which has generated considerable free cash flow and maintained margins on its product revenue. "Throughout 2023, we made targeted investments in our business and formed strategic relationships to further position ourselves for co ...

Wall Street expects a year-over-year decline in earnings on lower revenues when CryoPort, Inc. (CYRX) reports results for the quarter ended December 2023. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.The earnings report might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the sto ...

After reaching an important support level, CryoPort, Inc. (CYRX) could be a good stock pick from a technical perspective. CYRX recently experienced a "golden cross" event, which saw its 50-day simple moving average breaking out above its 200-day simple moving average.A golden cross is a technical chart pattern that can signify a potential bullish breakout. It's formed from a crossover involving a security's short-term moving average breaking above a longer-term moving average, with the most common moving av ...

Yes. Thanks, Jerry. Jerry is exactly right. ItÂ's a very complementary product to our existing SmartPack2 condition monitoring platform and will provide us more depth with different service levels and competencies from obviously high-end real-time monitoring, as well as all the way down to a disposable data logs or 1-way or uni-directional transit packaging. So itÂ's a very complementary product for us, the product suite itself will dovetail very nicely into what weÂ've built within our existing portfolio o ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______ to ______. Commission File Number: 001-34632 CRYOPORT, INC. (Exact Name of Registrant as Specified in its Charter) Nevada 88-0313393 ...

As a reminder, we have uploaded our second quarter 2023 and review document to our website. It can be found under the investor relations in the events and presentation section. This document provides a review of our financial and operational performance and a general business outlook. If you have not had a chance to read it, I would encourage you to download it at this time. Jerrell Shelton Todd Fromer - Investor Relations, KCSA Strategic Communications Jerrell Shelton Cryoport, Inc. (NASDAQ:CYRX) Q2 2023 E ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______ to ______. Commission File Number: 001-34632 CRYOPORT, INC. (Exact Name of Registrant as Specified in its Charter) (949) 470-2300 (Regist ...